Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AbobotulinumtoxinA for Platysmal Bands
NCT04080882Phase 2Completed
- Sponsor
- Galderma
- Start
- Sep 2019
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in Platysmal Bands, sponsored by Galderma. Started Sep 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Platysmal Bands
Beyond the preview
Go deeper on NCT04080882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04080882.